Recent posts

TypePostAuthorRepliesLast updated
Blog entryU.S. Army Rejects Pricing Concerns in Grant of Exclusive Patent License to Sanofi on Zika Vaccine KEI Staff08 hours 36 min ago
PageZika James Love010 hours 59 min ago
Blog entryFeb 24, 2017 - U.S. History, Experiences, and Prospects of Compulsory Licensing of Medical Patents Claire Cassedy04 days 9 hours ago
Blog entryKEI, UACT Request that Trump Administration Reevaluate Xtandi Petition Andrew Goldman04 days 12 hours ago
PageDecember 2, 2016 Delinkage Meeting: Powerpoints and Video Recording KEI Staff01 week 13 hours ago
PageXtandi March-in Request, links to news stories, blogs Zack Struver02 weeks 6 days ago
Blog entryKEI Statement on House Letter to President Trump on the Protection of Taxpayers’ Rights in Federally-Funded Inventions Zack Struver02 weeks 6 days ago
Blog entryDemocrats in House and Senate introduce new drug pricing bill James Love03 weeks 5 days ago
Blog entryKEI statement: 21st meeting of the WHO Expert Committee on the Selection and Use of Essential Medicines thiru04 weeks 15 hours ago
Blog entryDr. Elias Zerhouni defends Sanofi/Army proposed license on Zika patents, and KEI responds James Love04 weeks 5 days ago
Blog entry14 March 2017 - Senate Finance Committee grills Robert Lighthizer (USTR nominee) on trade and IPR policies thiru04 weeks 5 days ago
Blog entryMaryland House of Delegates passes bill on prescription drug price gouging by vote of 137 to 4 James Love04 weeks 6 days ago
Blog entryLeaked: Three documents from RCEP negotiations James Love04 weeks 6 days ago
Blog entryLeaked document: March 15, 2017 Note by Switzerland on India EFTA TEPA IP Chapter James Love04 weeks 6 days ago
Blog entryPatients, Members of Congress Ask Chilean Government to Issue Compulsory Licenses on Prostate Cancer and HCV Drug Patents Zack Struver04 weeks 6 days ago
Blog entryKEI Testifies in Maryland on Drug R&D Cost Transparency Bill (HB666/SB437) Zack Struver05 weeks 3 days ago
PageResearch and Development Cost Transparency Legislation Zack Struver05 weeks 4 days ago
Blog entryHHS Office of Inspector General Declines to Investigate Failure to Disclose Federal Funding in Ionis Pharmaceuticals' Spinraza Zack Struver05 weeks 4 days ago
Blog entrySpinraza: KEI asks DHHS Office of the Inspector General (OIG) to investigate a failure to disclose federal funding in patents James Love05 weeks 4 days ago
Book pageJames Love, Director James Love05 weeks 5 days ago
Blog entryCompany disclosures of R&D costs on SEC filings James Love06 weeks 13 hours ago
Blog entryKEI 10 March 2017 Comments on Army Exclusive License on Zika Virus Vaccine Patents to Sanofi KEI Staff06 weeks 14 hours ago
Blog entryDHHS declared public health emergency for Zika virus James Love06 weeks 3 days ago
Book pageKEI Board of Directors KEI Staff06 weeks 3 days ago
Blog entry2017 R&D Cost Transparency Proposals in the United States Zack Struver06 weeks 3 days ago